Established | 1984 (at its current location) |
---|---|
Research type | Radiobiology |
Field of research | Microbeam |
Director | David J. Brenner |
Address | P.O. Box 21 |
Location | Irvington, New York |
Affiliations | Columbia University National Institutes of Health National Institute of Biomedical Imaging and Bioengineering |
Website | www |
The Radiological Research Accelerator Facility (RARAF), [1] located on the Columbia University Nevis Laboratories campus in Irvington, New York is a National Institute of Biomedical Imaging and Bioengineering biotechnology resource center (P41) [2] specializing in microbeam technology. The facility is currently built around a 5MV Singletron, a particle accelerator similar to a Van de Graaff.
The RARAF microbeam can produce with high accuracy and precision:
RARAF was conceived by Victor P. Bond and Harald H. Rossi in the late 1960s . Their aim was to provide a source of monoenergetic neutrons designed and operated specifically for studies in radiation biology, dosimetry, and microdosimetry. The facility was built around the 4 MV Van de Graaff particle accelerator that originally served as the injector for the Cosmotron, a 2 GeV accelerator operated at Brookhaven National Laboratory (BNL) in the 1950s and 1960s.
RARAF operated at BNL from 1967 until 1980, when it was dismantled to make room for the ISABELLE project, a very large accelerator which was never completed. A new site for RARAF was found at the Nevis Laboratories of Columbia University where its cyclotron was being disassembled. The U.S. Department of Energy provided funds to move RARAF to Nevis Laboratories and reassemble it in a new multi-level facility constructed within the cyclotron building. The new RARAF has been routinely operating for research since mid-1984.
RARAF was one of the first three microbeam facilities [3] to be built, and it is the only original microbeam facility still in operation.
In 2006 the Van de Graaff was replaced by a 5 MV Singletron from High Voltage Engineering Europa (HVEE) in the Netherlands.
As an NIBIB biotechnology resource center, RARAF is dedicated to developing and improving microbeam technologies. Developments focus on adding and improving imaging techniques to the existing microbeam. Neutron and x-ray microbeams are also in development. Some examples of microbeam developments are listed below.
In order to focus charged particles in the RARAF microbeam, an electrostatic lens consisting of six quadrupole arranged in two triplets with each successive quadrupole rotated by 90° around its axis, is used. Each quadrupole triplet consists of 4 ceramic rods on which gold electrodes were plated. This design ensures alignment of the three quadrupoles in the triplet and allows a small pole-gap and better focusing properties.
Due to the nature of the RARAF microbeam, sub-cellular targets such as the cell nucleus or the cell cytoplasm have been possible for years. With a sub-micrometre diameter beam routinely available, additional targets within cellular systems are accessible. For instance, preliminary radiation experiments that target mitochondria have been conducted on small airway epithelial cells. [1]
During microbeam irradiation, cells to be irradiated are moved to the beam position using a high-speed high-resolution three-axis piezo-electric stage. [4] In order to further reduce targeting time, and making use of the fact that a focused microbeam, unlike a collimated one, is not restricted to a single location on the accelerator exit window, we have implemented a magnetic-coil-based fast deflector, placed between the two quadrupole triplets, that allows deflecting the beam to any position in the field of view of the microscope used to observe the cells during irradiation. Moving the beam to the cell position magnetically can be performed much faster than moving the stage. The deflector used in this system can move the beam to as many as 1000 separate locations per second—more than 5 times the speed of movement of the stage—dramatically reducing the irradiation time.
The RARAF microbeam is adding an x-ray microbeam using characteristic Kα x rays from Ti. The x rays will be generated using an electrostatic lens system to focus protons onto a thick Ti target. The x rays generated are demagnified using a zone plate. By using the already focused proton microbeam to generate characteristic x rays, it is possible to obtain a nearly monochromatic x-ray beam (very low bremsstrahlung yield) and a reasonably small x-ray source (~20 μm diameter), reducing the requirements on the zone plate.
There are considerable benefits in using soft x-ray microbeams for both mechanistic and risk estimation end-points. The higher spatial resolution achievable with modern state-of-the-art x-ray optics elements combined with the localized damage produced by the absorption of low energy photons (~1 keV) represents a unique tool to investigate the radio-sensitivity of sub-cellular and eventually sub-nuclear targets. Also, since low-energy x rays undergo very little scattering, by using x rays with an energy of ~5 keV it will be possible to irradiate with micrometre precision individual cells and/or parts of cells up to a few hundred micrometres deep inside a tissue sample in order to investigate the relevance of effects such as the bystander effect in 3-D structured cell systems.
RARAF is also a user facility for biologists interested in performing microbeam studies. The prominent theme of research undertaken using the RARAF microbeam is damage signal transduction, both within cells and between cells, which is of interest due in part to the discovery of the radiation-induced bystander effect. Early inter-cellular signal transduction studies were done with cells plated in 2D monolayers. More recently due to the significance of the extracellular environment and technological developments, studies involving 3D tissue systems, [5] [6] including living organisms, [7] have become more common.
RARAF is developing various microfluidic devices which add to the irradiation capabilities of the facility. The precision control and manipulation of fluids and biological materials afforded by microfluidics are ideal to interface with the microbeam. Additional microfluidic systems beyond those listed here are currently under development.
The Flow and Shoot microbeam system allows for controlled transport of cells through a microfluidic channel which intersects with the point and shoot microbeam. [8] A high speed camera allows for dynamic targeting of the flowing cells with flow rates of 1–10 mm/s, allowing for total throughput upwards of 100,000 cells per hour.
An optoelectronic tweezer platform has been interfaced with the RARAF microbeam. [9] This allows precision manipulation of cell position before, during, and after irradiation.
RARAF has implemented a microfluidic platform for the immobilization of Caenorhabditis elegans during microbeam irradiation. [10] The device avoids the use of anesthetics that might interfere with normal physiological processes by capturing the C. elegans worms in tapered microfluidic channels. It is possible to target specific regions of interest within C. elegans using this technology.
Broad beam irradiations are also possible. Particles with linear energy transfer (LET) between 10 and 200 keV/μm are available utilizing beams of protons, deuterons, helium-3, and helium-4 ions. Additionally, energetic and thermal neutrons and x rays can be used in broad beam irradiations.
RARAF has trained scientists at all levels: high school students, undergraduates, graduate students, post docs, and senior scientists. The lab estimates that about 45 scientists have received training in microbeam physics and or biology in the past 5 years.
RARAF is an active participant in the Columbia University Research Experience for Undergraduates program.
In addition, RARAF has become a de facto training center for developers of new microbeams. A virtual microbeam training course, complete with videos and handouts, is also available online.
DESY, short for Deutsches Elektronen-Synchrotron, is a national research centre for fundamental science located in Hamburg and Zeuthen near Berlin in Germany. It operates particle accelerators used to investigate the structure, dynamics and function of matter, and conducts a broad spectrum of interdisciplinary scientific research in four main areas: particle and high energy physics; photon science; astroparticle physics; and the development, construction and operation of particle accelerators. Its name refers to its first project, an electron synchrotron. DESY is publicly financed by the Federal Republic of Germany and the Federal States of Hamburg and Brandenburg and is a member of the Helmholtz Association.
External beam radiation therapy (EBRT) is a form of radiotherapy that utilizes a high-energy collimated beam of ionizing radiation, from a source outside the body, to target and kill cancer cells. A radiotherapy beam is composed of particles which travel in a consistent direction; each radiotherapy beam consists of one type of particle intended for use in treatment, though most beams contain some contamination by other particle types.
A linear particle accelerator is a type of particle accelerator that accelerates charged subatomic particles or ions to a high speed by subjecting them to a series of oscillating electric potentials along a linear beamline. The principles for such machines were proposed by Gustav Ising in 1924, while the first machine that worked was constructed by Rolf Widerøe in 1928 at the RWTH Aachen University. Linacs have many applications: they generate X-rays and high energy electrons for medicinal purposes in radiation therapy, serve as particle injectors for higher-energy accelerators, and are used directly to achieve the highest kinetic energy for light particles for particle physics.
In accelerator physics, a beamline refers to the trajectory of the beam of particles, including the overall construction of the path segment along a specific path of an accelerator facility. This part is either
A synchrotron is a particular type of cyclic particle accelerator, descended from the cyclotron, in which the accelerating particle beam travels around a fixed closed-loop path. The magnetic field which bends the particle beam into its closed path increases with time during the accelerating process, being synchronized to the increasing kinetic energy of the particles.
The Paul Scherrer Institute (PSI) is a multi-disciplinary research institute for natural and engineering sciences in Switzerland. It is located in the Canton of Aargau in the municipalities Villigen and Würenlingen on either side of the River Aare, and covers an area over 35 hectares in size. Like ETH Zurich and EPFL, PSI belongs to the Swiss Federal Institutes of Technology Domain of the Swiss Confederation. The PSI employs around 3000 people. It conducts basic and applied research in the fields of matter and materials, human health, and energy and the environment. About 37% of PSI's research activities focus on material sciences, 24% on life sciences, 19% on general energy, 11% on nuclear energy and safety, and 9% on particle physics.
In medicine, proton therapy, or proton radiotherapy, is a type of particle therapy that uses a beam of protons to irradiate diseased tissue, most often to treat cancer. The chief advantage of proton therapy over other types of external beam radiotherapy is that the dose of protons is deposited over a narrow range of depth; hence in minimal entry, exit, or scattered radiation dose to healthy nearby tissues.
Radiosurgery is surgery using radiation, that is, the destruction of precisely selected areas of tissue using ionizing radiation rather than excision with a blade. Like other forms of radiation therapy, it is usually used to treat cancer. Radiosurgery was originally defined by the Swedish neurosurgeon Lars Leksell as "a single high dose fraction of radiation, stereotactically directed to an intracranial region of interest".
A particle beam is a stream of charged or neutral particles. In particle accelerators, these particles can move with a velocity close to the speed of light. There is a difference between the creation and control of charged particle beams and neutral particle beams, as only the first type can be manipulated to a sufficient extent by devices based on electromagnetism. The manipulation and diagnostics of charged particle beams at high kinetic energies using particle accelerators are main topics of accelerator physics.
In dosimetry, linear energy transfer (LET) is the amount of energy that an ionizing particle transfers to the material traversed per unit distance. It describes the action of radiation into matter.
The Mainz Microtron, abbreviated MAMI, is a microtron which provides a continuous wave, high intensity, polarized electron beam with an energy up to 1.6 GeV. MAMI is the core of an experimental facility for particle, nuclear and X-ray radiation physics at the Johannes Gutenberg University in Mainz (Germany). It is one of the largest campus-based accelerator facilities for basic research in Europe. The experiments at MAMI are performed by about 200 physicists of many countries organized in international collaborations.
Fast neutron therapy utilizes high energy neutrons typically between 50 and 70 MeV to treat cancer. Most fast neutron therapy beams are produced by reactors, cyclotrons (d+Be) and linear accelerators. Neutron therapy is currently available in Germany, Russia, South Africa and the United States. In the United States, one treatment center is operational, in Seattle, Washington. The Seattle center uses a cyclotron which produces a proton beam impinging upon a beryllium target.
The radiation-induced bystander effect is the phenomenon in which unirradiated cells exhibit irradiated effects as a result of signals received from nearby irradiated cells. In November 1992, Hatsumi Nagasawa and John B. Little first reported this radiobiological phenomenon.
Particle therapy is a form of external beam radiotherapy using beams of energetic neutrons, protons, or other heavier positive ions for cancer treatment. The most common type of particle therapy as of August 2021 is proton therapy.
Intraoperative electron radiation therapy is the application of electron radiation directly to the residual tumor or tumor bed during cancer surgery. Electron beams are useful for intraoperative radiation treatment because, depending on the electron energy, the dose falls off rapidly behind the target site, therefore sparing underlying healthy tissue.
A particle accelerator is a machine that uses electromagnetic fields to propel charged particles to very high speeds and energies to contain them in well-defined beams. Large accelerators are used for fundamental research in particle physics. Accelerators are also used as synchrotron light sources for the study of condensed matter physics. Smaller particle accelerators are used in a wide variety of applications, including particle therapy for oncological purposes, radioisotope production for medical diagnostics, ion implanters for the manufacture of semiconductors, and accelerator mass spectrometers for measurements of rare isotopes such as radiocarbon.
A microbeam is a narrow beam of radiation, of micrometer or sub-micrometer dimensions. Together with integrated imaging techniques, microbeams allow precisely defined quantities of damage to be introduced at precisely defined locations. Thus, the microbeam is a tool for investigators to study intra- and inter-cellular mechanisms of damage signal transduction.
Neutron capture therapy (NCT) is a type of radiotherapy for treating locally invasive malignant tumors such as primary brain tumors, recurrent cancers of the head and neck region, and cutaneous and extracutaneous melanomas. It is a two-step process: first, the patient is injected with a tumor-localizing drug containing the stable isotope boron-10 (10B), which has a high propensity to capture low energy "thermal" neutrons. The neutron cross section of 10B is 1,000 times more than that of other elements, such as nitrogen, hydrogen, or oxygen, that occur in tissue. In the second step, the patient is radiated with epithermal neutrons, the sources of which in the past have been nuclear reactors and now are accelerators that produce higher energy epithermal neutrons. After losing energy as they penetrate tissue, the resultant low energy "thermal" neutrons are captured by the 10B atoms. The resulting decay reaction yields high-energy alpha particles that kill the cancer cells that have taken up enough 10B.
The Sarayköy Nuclear Research and Training Center, known as SANAEM, is a nuclear research and training center of Turkey. The organization was established on July 1, 2005, as a subunit of Turkish Atomic Energy Administration at Kazan district in northwest of Ankara on an area of 42.3 ha.
Monitored neutrino beams are facilities for the production of neutrinos with unprecedented control of the flux of particles created inside and outside the facility.